Article info
Recent advances in basic science
From the origin of NASH to the future of metabolic fatty liver disease
- Correspondence to Professor Andreas Geier, Medical Center, Division of Hepatology, University of Würzburg, Wurzburg, Bayern, Germany; Geier_A2{at}medizin.uni-wuerzburg.de
Citation
From the origin of NASH to the future of metabolic fatty liver disease
Publication history
- Received September 28, 2020
- Revised January 13, 2021
- Accepted February 5, 2021
- First published February 25, 2021.
Online issue publication
July 12, 2021
Article Versions
- Previous version (25 February 2021).
- Previous version (2 March 2021).
- Previous version (5 March 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.